cerrar
Tagged with generics

John Bouros – CEO, Alvion Pharmaceuticals, Greece
John Bouros CEO and founder of Alvion Pharmaceuticals in Greece on the opportunities inherent in any economic crisis, the growth of the Greek generics…

Interview PH Huang – Chairman & CEO, JCP Works, Taiwan
JCP is home to over five decades of generic medication production and is a cornerstone household brand for numerous products in Taiwan’s domestic…

Parallel Trade in Polish Pharma: The Good and the Bad
Poland’s entrance into the EU has been a catalyst for growth that has allowed the country to flourish, shown by the nation’s ranking as the…

Interview: Fangchen Lee – Chairman, YungShin Global…
Fangchen Lee, Chairman of YungShin Global Holding on strengthening the groups's vertical integration, expanding product portfolio, and instilling…

Europe Facts & Figures Snapshot
Europe accounts for 22.2 percent of global pharma sales; more than Africa, Asia, Australasia, and Latin America combined, but less than half of North…

Interview: MS Nagendra – Director General, Zydus…
M.S. Nagendra, Director General at Zydus Pharmaceuticals Mexico, explains the company’s unique business model, combining both branded generics and…

Interview: Paulo de Resende – CEO, Laboratorios Grin-Lupin,…
Paulo de Resende, CEO of Laboratorios Grin-Lupin in Mexico, describes the current state of the Mexican pharmaceutical market and explains how the…

Eugenia Nicolaou – CEO, Anfarm, Greece
Carrying the legacy of an accomplished Greek family business, Anfarm CEO Eugenia Nicolaou speaks proudly about the company’s evolution, how Anfarm…

Interview: Thierry Volle – President EMEA, Lupin
Lupin’s EMEA President Thierry Volle explains that to fuel growth in the EMEA region, Lupin is investing heavily in transforming the business from a…

Interview: Yita Lee Ph.D – Deputy Chairman, Sinphar Group;…
Yita Lee & Muh-Hwan Su of Sinphar Group & SynCore Bio describe the exciting R&D projects of SynCore Bio, the oncology & dry AMD…

Interview: Piero Poli – President & CEO, Rivopharm,…
Niche generics manufacturer Rivopharm was nearly bankrupt when acquired by current president and CEO Piero Poli in 2005; he explains the changes and…

Interview: Juan Francisco Hernández – General Manager…
Juan Francisco Hernández, general manager of Latin America at Wockhardt, showcases the added value of the company to the entire region based on…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here